TY  - CONF
AU  - Pérez-Hernández, Isabel A
AU  - Palacios, Rosario
AU  - Mayorga, Marisa
AU  - González-Doménech, Carmen M
AU  - Castaño, Manuel
AU  - Rivero, Antonio
AU  - Arco, Alfonso del
AU  - Lozano, Fernando
AU  - Santos, Jesús
PY  - 2014
UR  - http://hdl.handle.net/10668/1856
T2  - Journal of the International AIDS Society
AB  - INTRODUCTIONRilpivirine (RPV) has a better lipid profile than efavirenz (EFV) in naïve patients (1). Switching to RPV may be convenient for many patients, while maintaining a good immunovirological control (2). The aim of this study was to analyze...
LA  - en
PB  - BioMed Central
KW  - Infecciones por VIH
KW  - Fármacos anti-VIH
KW  - Combinación de medicamentos
KW  - Lípidos
KW  - Inhibidores de transcriptasa inversa
KW  - Inhibidores de la Sintesis del ácido nucleico
KW  - Antígenos CD4
KW  - Lipoproteínas HDL
KW  - Compuestos organofosforados
KW  - Inhibidores de proteasas
KW  - Enfermedades cardiovasculares
KW  - Factores de riesgo
KW  - Genotipo
KW  - Medical Subject Headings::Diseases::Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::HIV Infections
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antiviral Agents::Anti-Retroviral Agents::Anti-HIV Agents
KW  - Medical Subject Headings::Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinations
KW  - Medical Subject Headings::Chemicals and Drugs::Lipids
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Nucleic Acid Synthesis Inhibitors::Reverse Transcriptase Inhibitors
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Nucleic Acid Synthesis Inhibitors
KW  - Medical Subject Headings::Chemicals and Drugs::Biological Factors::Antigens::Antigens, Surface::Antigens, Differentiation::Antigens, CD::Antigens, CD4
KW  - Medical Subject Headings::Chemicals and Drugs::Lipids::Lipoproteins::Lipoproteins, HDL
KW  - Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Organophosphorus Compounds
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protease Inhibitors
KW  - Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
KW  - Medical Subject Headings::Diseases::Cardiovascular Diseases
KW  - Medical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Probability::Risk::Risk Factors
KW  - Medical Subject Headings::Check Tags::Male
KW  - Medical Subject Headings::Phenomena and Processes::Genetic Phenomena::Genotype
TI  - Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera®). Efficacy and safety analysis. GeSida Study 8114.
TY  - conference presentation
ER  -